1 / 4

The Amebiasis Treatment Can Offer Opportunities for Payers as Consumer Demand for Cost-Effective Pharmaceuticals Rises

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica.<br>

rushi12
Télécharger la présentation

The Amebiasis Treatment Can Offer Opportunities for Payers as Consumer Demand for Cost-Effective Pharmaceuticals Rises

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Amebiasis Treatment Market - Size, Share, Amebiasis Treatment Market - Size, Share, Growth, Outlook, and Opportunity Analysis, Growth, Outlook, and Opportunity Analysis, 2018-2026 2018-2026 Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain. Amebiasis is common in regions with low developed sanitation facilities such as Asia Pacific, Central America, South America, and some parts of Africa. Amebiasis is mainly transmitted through water or food contaminated with Entamoeba Histolytica. Amebiasis can lead to diarrhea (with or without blood) in both adults and children, leading to high morbidity and mortality. The organism, Entamoeba Histolytica, can damage organ and may require surgical intervention, if the colon and other tissues have undergone perforation. However, amebiasis can be treated with some antibiotic, anti- parasitic, and antiprotozoal drugs such as metronidazole, paromomycin, and tinidazole. Diagnosis of this disease is usually made by microscopic identification of the microorganism in a stool specimen. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1595 Amebiasis Treatment Market Drivers Increasing approvals and launches of new drugs indicated for the treatment of amebiasis is expected to be a major factor for growth of amebiasis treatment market. For instance, in 2017, Dr. Reddy's Laboratories received U.S. Food and Drug Administration (FDA) approval for its Minolira (minocycline) extended-release tablets, indicated for the treatment of a variety of bacterial infections and as adjunctive therapy in acute intestinal amebiasis. Moreover, in 2016, Rising Pharmaceuticals, Inc.—a subsidiary of Aceto Corporation—launched Metronidazole Tablets, 250mg and 500mg, generic version of Flagyl manufactured by G.D. Searle, LLC’s, indicated for the treatment of amebiasis and a variety of anaerobic bacterial infections. In 2016, Mylan Pharmaceuticals Inc. received ANDA approval for its Doryx (Doxycycline Hyclate) Delayed- Release Tablets, 50 mg, indicated for the treatment of acute intestinal amebiasis. Amebiasis Treatment Market Regional Analysis

  2. Africa is expected to show a significant growth in the global amebiasis treatment market over the forecast period, owing to high prevalence rate of amebiasis due to poor sanitation and low availability of clean drinking water. For instance, according to data published by United Nations Department of Economic and Social Affairs (UNDESA), in 2014, around 115 people in Africa die every hour from diseases linked to poor sanitation, poor hygiene, and contaminated water. In Sub-Saharan Africa around 40% of the 783 million people do not have access to a clean source of drinking water. Furthermore, Asia Pacific region is expected to show significant growth in amebiasis treatment market over the forecast period, owing to increasing prevalence of amebiasis in some rural areas of India and China. For instance, according to data published on National Health Portal of India, in 2015, amebiasis affected about 15% of the total population in India. Report includes chapters which deeply display the following deliverable about industry : • Amebiasis Treatment Market Research Objective and Assumption • Amebiasis Treatment Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Amebiasis Treatment Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Amebiasis Treatment Market, By Regions • Amebiasis Treatment Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Amebiasis Treatment Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Amebiasis Treatment Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Amebiasis Treatment Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Amebiasis Treatment Market Key Players

  3. Key players operating in amebiasis treatment market include Pfizer Inc., Impax Laboratories, Lupin Pharmaceuticals, Inc., Sanofi, Actelion Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Sun Pharmaceutical Industries Inc., Heritage Pharmaceuticals Inc., Mission Pharmacal Co., Novel Laboratories, and others. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1595 Amebiasis Treatment Market Taxonomy: The global amebiasis treatment market is segmented on the basis of drug type, distribution channel, and region: By Drug Type- Metronidazole Paromomycin Tinidazole Iodoquinol Dehydroemetine Chloroquine phosphate Others • • • • • • • By Distribution Channel- Hospitals Online Pharmacies Retail Pharmacies • • • By Region North America Latin America Europe Asia Pacific Middle East Africa • • • • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis

  4. through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

More Related